ArvinBio

Research & Technology

Research Team

Sejong ABin Biotech's technology is the fruit of 29 years of academic rigor at Ajou University, integrating cutting-edge convergence fields such as protein engineering and bioinformatics.

Dr. Min Churl-ki Β· Director & CTO

Dr. Min Churl-ki Β· Director & CTO

A Ph.D. in pharmacology from Cornell University, he served as a professor in Ajou University's Department of Life Sciences for about 29 years. His work spans genetic engineering, protein engineering, and bioinformatics, focusing on stem-cell-based treatment of intractable diseases.

  • B.S. and M.S. from Seoul National University; Ph.D. in pharmacology, Cornell University (1991)
  • Postdoctoral fellow at Caltech, USA (1991–1993)
  • Professor, Department of Life Sciences, Ajou University for ~29 years
  • Fields: genetic engineering, protein engineering, bioinformatics
  • Holds multiple patents including RGMc-based stem-cell induction medium
Dr. Kim Hae-kwon Β· Research Advisor

Dr. Kim Hae-kwon Β· Research Advisor

He earned a Ph.D. in zoology from Seoul National University and conducted postdoctoral research at the UK MRC and Johns Hopkins University. He served as professor in the Department of Life and Environmental Engineering and as Dean of the College of Natural Sciences at Seoul Women's University, and now serves as a research advisor to Sejong ABin Biotech.

  • B.S., M.S., Ph.D. in zoology, Seoul National University
  • Postdoctoral research at UK MRC and Johns Hopkins University
  • Former Dean, College of Natural Sciences, Seoul Women's University
  • President, Korean Society for Reproductive Medicine
  • Editorial board, 'World Journal of Stem Cells' (2009–2013)
  • Fields: cell therapeutics, stem-cell differentiation

A Research Philosophy Built on Convergence

The team's patent portfolio is the fruit of long-standing academic rigor, integrating cutting-edge convergence fields such as protein engineering and bioinformatics.

  • Mitochondria & telomere protection: suppressing cell aging and maximizing energy-metabolism efficiency
  • Proprietary induction medium (RGMc): high-efficacy stem-cell induction
  • RNA/PNA delivery systems: next-generation nucleic-acid platform technology
  • Neurology: differentiation for Parkinson's and Alzheimer's disease
  • Metabolism: inducing insulin-secreting cells for diabetes treatment

This content is provided for general informational purposes only, and individual treatment outcomes may vary.

Explore Stem Cell Care with a Consultation

Our specialized medical team provides consultations tailored to your individual health condition and goals.